Overview


The Stent Delivery Systems Market encompasses the global industry dedicated to developing, manufacturing, and commercialising medical devices that deploy stents within arteries or other vessels to restore proper blood flow.

According to FutureWise analysis, the Stent Delivery Systems Market in 2026 is US$12.37 billion and is expected to reach US$24.10 billion by 2036 at a CAGR of 6.90%. The growth is fueled by the rising prevalence of cardiovascular diseases, advancements in minimally invasive procedures, and the increased use of drug-eluting and bioresorbable stents. Innovations in stent delivery technology and improved imaging guidance are also enhancing procedural success rates and patient outcomes.

Growth Drivers:

  • Rising prevalence of cardiovascular diseases globally.
  • Growing adoption of minimally invasive procedures over open surgeries.
  • Technological advancements in drug-eluting and bioresorbable stents.
  • An increasing geriatric population with a higher risk of vascular disorders.
  • Expansion of healthcare infrastructure in emerging markets.

Key Trends:

  • Rising preference for minimally invasive and catheter-based procedures.
  • Growth of drug-eluting and bioresorbable stents for improved patient outcomes.
  • Integration of smart, precision-delivery technologies into stent systems.
  • Expansion of emerging markets due to increasing cardiovascular awareness.
  • Focus on personalised, patient-specific stent designs to improve efficacy.

Market Segmentation and Key Players:

The Stent Delivery Systems Market is segmented by material type, end user, and region. Key materials include Cobalt-Chromium and stent-on-a-wire systems, showcasing technological differences. End users consist of hospitals, ambulatory surgical centres, and catheterisation labs. Regionally, North America leads due to advanced infrastructure, followed by Latin America, Europe, Asia Pacific, and the Middle East & Africa. Comprehensive segmentation details are provided in the Segmentation section below.

Major companies operating in the Stent Delivery Systems Market, like Boston Scientific and Medtronic, drive innovation and market presence.

Research Methodology:

The research methodology for the Stent Delivery Systems Market by FutureWise Research combines primary and secondary research for accurate insights. Primary research includes interviews with key industry stakeholders, such as manufacturers and healthcare professionals, to gather firsthand data on trends and technologies. Secondary research involves analysing company reports, industry publications, and regulatory databases to validate the findings.

  • Boston Scientific Corporation
  • Abbott
  • B. Braun Melsungen AG
  • Medtronic
  • Stryker
  • Biotronik
  • C.R. Bard

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Stent Delivery Systems Market:

Boston Scientific 

In March 2024, the FDA approved Agent, the first drug-coated balloon catheter available in the U.S. for treating coronary in-stent restenosis (ISR). This device utilizes paclitaxel to reopen narrowed vessels and significantly reduces the recurrence of ISR.

Medtronic

Medtronic has launched the Neuroguard IEP System, a carotid stent and embolic protection device designed to prevent distal embolization during stent placement. This system enhances procedural safety in carotid artery stenting procedures by integrating embolic protection directly into the stent delivery catheter, thereby streamlining the overall process.

By Material Type

  • Cobalt-Chromium Delivery System
  • Stent-on-a-wire delivery system
  • Others

By End User

  • Hospital
  • Ambulatory Surgical Centres
  • Catheterization Laboratories

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Here’s a regional view of where the most progress is happening:

North America is at the forefront of developing Stent Delivery Systems due to several key factors: leadership in market share, a high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and robust regulatory support.

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the global Stent Delivery Systems Market By Material Type, By End-user, and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Stent Delivery Systems Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Stent Delivery Systems Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Stent Delivery Systems Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Stent Delivery Systems Market, By Material Type Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. Cobalt-Chromium Delivery System
        2. Stent-on-a-wire delivery system
        3. Others

  • 8.   Stent Delivery Systems Market, By End User Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. Hospital
        2. Ambulatory Surgical Centres
        3. Catheterization Laboratories

  • 9.   North America Stent Delivery Systems Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2026-2036

  • 10.   Latin America Stent Delivery Systems Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2026-2036

  • 11.   Europe Stent Delivery Systems Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2026-2036

  • 12.   Asia Pacific Stent Delivery Systems Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2026-2036

  • 13.   Middle East and Africa Stent Delivery Systems Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2026-2036

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Boston Scientific Corporation
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Abbott
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. B. Braun Melsungen AG
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Medtronic
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Stryker
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Biotronik
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. C.R. Bard
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client

FAQ


Stent delivery systems are medical devices designed to insert stents into narrowed or blocked arteries, restoring proper blood circulation. These systems consist of the stent itself, catheters, and other delivery tools for performing minimally invasive cardiovascular procedures.

Increasing prevalence of cardiovascular diseases, including coronary artery disease (CAD), greater adoption of minimally invasive procedures, and advancements in technology such as drug-eluting stents (DES) and bioresorbable scaffolds.

Major end-users include hospitals, catheterization laboratories, and ambulatory surgical centers. Hospitals remain the largest consumers due to high volumes of percutaneous coronary interventions (PCI), while specialized labs adopt advanced delivery systems for minimally invasive cardiovascular procedures.

High costs of advanced stent technologies, strict regulatory requirements, and the need for trained medical professionals to operate sophisticated delivery systems.

Related Market

Heparin Coated Stent Market

Read More

Stent Grafts Market

Read More

Stent Graft Balloon Catheter Market

Read More
Partner

Our Clients